Results 51 to 60 of about 209,994 (252)
The new coronavirus infection COVID-19 from the moment of the first message to the present has spread rapidly in more than two hundred countries around the world, posing a serious threat to the life and health of the population.
O. A. Polyakova +5 more
doaj +1 more source
New Onset of Fibromyalgia After Exposure to a Combat Environment: A Longitudinal Cohort Study
Objective Traumatic life events are hypothesized to be triggers for the onset of fibromyalgia. Posttraumatic stress disorder (PTSD) is a common comorbidity of fibromyalgia. However, limited prospective data are available on the development of fibromyalgia after exposure to high‐magnitude stress.
Jay B. Higgs +15 more
wiley +1 more source
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang +6 more
wiley +1 more source
Post COVID-19 syndrome in a prospective cohort study of Egyptian patients
Background Post-coronavirus disease (COVID-19) syndrome is defined as the persistence of symptoms for more than 3 to 12 weeks after infection with the COVID-19 virus that cannot be attributed to another etiology.
Dalia Mohamed Gamal +2 more
doaj +1 more source
Multidimensional laser‐induced graphene (LIG) spanning from 0D to 3D architectures is comprehensively reviewed for multifunctional biomedical platforms, including biosensing, theranostics, and bioactive interface applications, which highlights its potentials for point‐of‐care diagnostics, wearable health monitoring, smart drug delivery, and tissue ...
Li Zhang +3 more
wiley +1 more source
Advances in Cancer Immunotherapy for Solid Tumors
Cancer immunotherapy for solid tumors is rapidly evolving beyond classical checkpoint blockade toward more precise strategies. Emerging checkpoint targets, bispecific antibodies, antibody–drug conjugate combinations, personalized vaccines, cellular therapies, and engineered cytokines are expanding therapeutic possibilities, while biomarker‐guided ...
Shira Gabizon‐Peretz +1 more
wiley +1 more source
Semi-quantitative CT severity scoring as a predictor of development of post-COVID syndrome
Background Following COVID-19 pandemic, clinical description focused on the clinical presentation of patients in the acute stage of the disease. More recently, data have emerged that some patients continue to experience symptoms related to COVID-19 after
Mohammad A. Saad +3 more
doaj +1 more source
NEUROPSYCHIATRIC CONSEQUENCES OF COVID-19
A review of the literature is devoted to post-COVID neuropsychiatric disorders. The article reveals the concept of post-COVID syndrome, provides the definitions of NICE and WHO, describes the clinical picture of post-COVID as a systemic disease. Data are
N. N. Petrova
doaj +1 more source
Epidemiology of post-COVID syndrome
As per the World Health Organization's (WHO) definition, post-COVID syndrome or long COVID refers to the persistence or emergence of new symptoms three months after the initial infection with the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2), and lasting for a minimum of two months, while excluding alternative diagnoses.
Gorica Marić +2 more
openaire +2 more sources
Unlike deceased‐donor liver transplantation, living‐donor liver transplantation (LDLT) for Budd‐Chiari Syndrome (BCS) presents distinctive challenges in hepatic venous (HV)‐outflow reconstruction because diseased HV–inferior vena cava (IVC) cannot be entirely replaced with healthy donor vessels.
Koichiro Hata +4 more
wiley +1 more source

